OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE DIAGNOSIS AND FOLLOW-UP OF RETINAL ARTERIAL MACROANEURYSMS.


Journal

Retinal cases & brief reports
ISSN: 1937-1578
Titre abrégé: Retin Cases Brief Rep
Pays: United States
ID NLM: 101298744

Informations de publication

Date de publication:
01 Jan 2021
Historique:
pubmed: 27 4 2018
medline: 12 10 2021
entrez: 27 4 2018
Statut: ppublish

Résumé

To describe optical coherence tomography angiography (OCTA) findings in retinal arterial macroaneurysm (RAM) associated with macular edema and to correlate OCTA findings with conventional multimodal imaging. The clinical course, conventional multimodal imaging findings including fundus color photography, spectral domain optical coherence tomography (Spectralis; Heidelberg Engineering, Heidelberg, Germany), fluorescein angiography (Heidelberg Engineering), and OCTA (Optovue, Inc, Freemont, CA) findings at baseline and during the follow-up of two eyes (two patients) with symptomatic RAM associated with macular edema were documented. Two eyes of 2 patients, both women, aged 82 and 46 years, which presented with progressive visual decline, were included. On conventional multimodal imaging, exudative RAM with macular edema and lipid exudation were visible in both included eyes. On OCTA, the flow in the two RAM was detected at baseline. Case 1 was treated by focal laser photocoagulation. One month after treatment, fluorescein angiography showed RAM occlusion. Spectral domain optical coherence tomography showed a RAM and retinal thinning and a decreased central foveal thickness, resulting in visual acuity improvement. On OCTA, no flow was detectable in the RAM at 1-month follow-up. Case 2 was not treated at baseline. In this eye, no flow was detected on OCTA at 2-month follow-up. This suggests a spontaneous occlusion, which was confirmed by fluorescein angiography. Optical coherence tomography angiography is able to detect the presence or absence of flow signal within RAMs, which may both decrease the need for dye angiography in selected cases with exudative RAM and help in treatment decision making.

Identifiants

pubmed: 29697600
pii: 01271216-202101510-00001
doi: 10.1097/ICB.0000000000000741
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Références

Panton RW, Goldberg MF, Farber MD. Retinal arterial macroaneurysms: risk factors and natural history. Br J Ophthalmol 1990;74:595–600.
Moosavi RA, Fong KC, Chopdar A. Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients. Eye (Lond) 2006;20:1011–1020.
Koinzer S, Heckmann J, Tode J, et al. Long-term, therapy-related visual outcome of 49 cases with retinal arterial macroaneurysm: a case series and literature review. Br J Ophthalmol 2015;99:1345–1353.
Chen YY, Lin LY, Chang PY, et al. Laser and anti-vascular endothelial growth factor agent treatments for retinal arterial macroaneurysm. Asia Pac J Ophthalmol (Phila) 2017;6:444–449.
Rabb MF, Gagliano DA, Teske MP. Retinal arterial macroaneurysms. Surv Ophthalmol 1988;33:73–96.
Hughes EL, Dooley IJ, Kennelly KP, et al. Angiographic features and disease outcomes of symptomatic retinal arterial macroaneurysms. Graefes Arch Clin Exp Ophthalmol 2016;254:2203–2207.
Hanhart J, Strassman I, Rozenman Y. En face imaging of retinal artery macroaneurysms using swept-source optical coherence tomography. Retin Cases Brief Rep 2017;11:211–216.
Lee EK, Woo SJ, Ahn J, et al. Morphologic characteristics of retinal arterial macroaneurysm and its regression pattern on spectral-domain optical coherence tomography. Retina 2011;31:2095–2101.
Sebrow DB, Cunha de Souza E, Belucio Neto J, et al. Macroaneurysms associated with congenital retinal macrovessels. Retin Cases Brief Rep 2017. E Pub Ahead of Press Aug 9, 2017.
Cleary PE, Kohner EM, Hamilton AM, et al. Retinal macroaneurysms. Br J Ophthalmol 1975;59:355–361.

Auteurs

Polina Astroz (P)

Department of Ophthalmology, Intercity Hospital and University Paris Est, Créteil, France.

Alexandra Miere (A)

Department of Ophthalmology, Intercity Hospital and University Paris Est, Créteil, France.

Salomon Yves Cohen (SY)

Department of Ophthalmology, Intercity Hospital and University Paris Est, Créteil, France.
Centre Ophtalmologique d'Imagerie et de Laser, Paris, France; and.

Giuseppe Querques (G)

Department of Ophthalmology, Intercity Hospital and University Paris Est, Créteil, France.
Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy.

Eric H Souied (EH)

Department of Ophthalmology, Intercity Hospital and University Paris Est, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH